NEW STUDIY. An ultra-sensitive blood test that reflects brain damage after acute ischemic stroke – and also predicts functional outcome. This is a discovery that is expected to be of great significance in the future. The findings are described in a study from the University of Gothenburg. The study, published in the journal Neurology, was conducted by a group of researchers at Sahlgrenska Academy at the University of Gothenburg led…
Dissatisfaction with postnatal care during the pandemic
NEW STUDY. “An absurd decision”, “a scandal”, and “I meant nothing”. These are some harsh words when describing the ban on partners in postnatal wards during the pandemic, from a partner perspective. A study from the University of Gothenburg reveals a picture of how the exclusion was perceived. In many parts of the country, the COVID-19 pandemic meant that partners of new mothers were not allowed in the postnatal clinic.…
Disrupted cellular function behind type 2 diabetes in obesity
NEW STUDY. Disrupted function of “cleaning cells” in the body may help to explain why some people with obesity develop type 2 diabetes, while others do not. A study from the University of Gothenburg describes this newly discovered mechanism. It is well known that obesity increases the risk of insulin resistance and type 2 diabetes. It is also well known that some people who gain weight suffer from the disease…
A tie between the most common obesity surgeries
NEW STUDY. The two most common obesity surgeries – gastric bypass and gastric sleeve – have few short-term complications and are equivalent in that sense. These are the findings of a study conducted at the University of Gothenburg. Every year, around 5,000 obesity surgeries are performed in Sweden. The person undergoing surgery will normally have a BMI of at least 40, or 35 if they also have other serious medical…
Study paves the way for precision treatment of type 2 diabetes
NEW STUDY. GLP1 medicines work best for those diabetes patients who have a reduced production of insulin. The study from the University of Gothenburg shows that it is possible to personalize the treatment of type 2 diabetes. This is the first clinical study to systematically test whether personalizing medical treatment of type 2 diabetes can work, and how such personalization could work in the healthcare practice. The results of the…